| Natural product bioactivities and synthesis | Lifetime | 3 | SG 1 | 99.88 |
| Bioactive Compounds and Antitumor Agents | Lifetime | 4 | SG 1 | 99.87 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 22 | SG 1 | 99.77 |
| NF-κB Signaling Pathways | Lifetime | 17 | SG 1 | 99.71 |
| Natural Compounds in Disease Treatment | Lifetime | 2 | SG 1 | 99.63 |
| Cancer Mechanisms and Therapy | Lifetime | 47 | SG 1 | 99.24 |
| Pharmacological Effects of Medicinal Plants | Lifetime | 8 | SG 1 | 98.94 |
| Cancer-related molecular mechanisms research | Lifetime | 348 | SG 3 | 98.78 |
| Curcumin's Biomedical Applications | Lifetime | 38 | SG 1 | 98.61 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 131 | SG 1 | 98.73 |
| Nigella sativa pharmacological applications | Lifetime | 13 | SG 1 | 98.36 |
| Genomics, phytochemicals, and oxidative stress | Lifetime | 182 | SG 2 | 98.04 |
| Autophagy in Disease and Therapy | Lifetime | 283 | SG 3 | 97.96 |
| Pharmacological Effects of Natural Compounds | Lifetime | 356 | SG 1 | 97.50 |
| Ferroptosis and cancer prognosis | Lifetime | 288 | SG 3 | 96.61 |
| Cancer, Lipids, and Metabolism | Lifetime | 559 | SG 2 | 97.94 |
| Phytochemical compounds biological activities | Lifetime | 137 | SG 1 | 97.22 |
| Circular RNAs in diseases | Lifetime | 488 | SG 5 | 97.10 |
| Cancer Cells and Metastasis | Lifetime | 670 | SG 4 | 97.32 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 58 | SG 2 | 94.53 |
| Retinoids in leukemia and cellular processes | Lifetime | 354 | SG 1 | 97.03 |
| Extracellular vesicles in disease | Lifetime | 717 | SG 7 | 95.01 |
| Quinazolinone synthesis and applications | Lifetime | 295 | SG 1 | 94.84 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 378 | SG 3 | 92.96 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 433 | SG 4 | 92.48 |
| Chemokine receptors and signaling | Lifetime | 718 | SG 2 | 91.76 |
| Phytochemical Studies and Bioactivities | Lifetime | 453 | SG 2 | 90.67 |
| Phytochemistry and Bioactive Compounds | Lifetime | 462 | SG 1 | 89.14 |
| Bioactive natural compounds | Lifetime | 479 | SG 2 | 88.61 |
| Phytochemicals and Medicinal Plants | Lifetime | 799 | SG 2 | 83.95 |
| Berberine and alkaloids research | Lifetime | 632 | SG 2 | 83.85 |
| Ginger and Zingiberaceae research | Lifetime | 722 | SG 3 | 81.47 |
| Flavonoids in Medical Research | Lifetime | 664 | SG 1 | 78.97 |
| Chemotherapy-induced organ toxicity mitigation | Lifetime | 889 | SG 1 | 78.20 |
| Phytochemistry and biological activity of medicinal plants | Lifetime | 828 | SG 4 | 74.42 |
| Magnolia and Illicium research | Lifetime | 304 | SG 1 | 68.86 |
| Cancer Cells and Metastasis | 2021-2025 | 4 | SG 1 | 99.24 |
| Cancer-related molecular mechanisms research | 2021-2025 | 35 | SG 1 | 99.61 |
| Cancer Mechanisms and Therapy | 2021-2025 | 8 | SG 1 | 99.07 |
| Autophagy in Disease and Therapy | 2021-2025 | 18 | SG 1 | 98.61 |
| Natural product bioactivities and synthesis | 2021-2025 | 31 | SG 1 | 97.62 |
| Bioactive Compounds and Antitumor Agents | 2021-2025 | 12 | SG 1 | 97.28 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 24 | SG 2 | 96.63 |
| Circular RNAs in diseases | 2021-2025 | 91 | SG 1 | 97.63 |
| MicroRNA in disease regulation | 2021-2025 | 193 | SG 1 | 97.44 |
| RNA modifications and cancer | 2021-2025 | 365 | SG 3 | 96.81 |
| Extracellular vesicles in disease | 2021-2025 | 281 | SG 4 | 95.41 |
| Ferroptosis and cancer prognosis | 2021-2025 | 350 | SG 2 | 95.04 |
| Epigenetics and DNA Methylation | 2021-2025 | 587 | SG 3 | 92.86 |
| Cancer-related gene regulation | 2021-2025 | 182 | SG 1 | 91.73 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 186 | SG 1 | 92.04 |
| NF-κB Signaling Pathways | 2021-2025 | 41 | SG 1 | 85.15 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 97 | SG 1 | 87.32 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 146 | SG 2 | 85.71 |
| Curcumin's Biomedical Applications | 2021-2025 | 149 | SG 1 | 85.82 |
| Cancer Research and Treatments | 2021-2025 | 614 | SG 3 | 82.58 |
| Estrogen and related hormone effects | 2021-2025 | 396 | SG 2 | 82.39 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 117 | SG 1 | 79.80 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 407 | SG 1 | 80.62 |
| Chemokine receptors and signaling | 2021-2025 | 167 | SG 1 | 79.25 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 204 | SG 1 | 78.48 |
| Cannabis and Cannabinoid Research | 2021-2025 | 885 | SG 1 | 81.53 |
| Liver physiology and pathology | 2021-2025 | 660 | SG 4 | 72.44 |
| Phytochemicals and Medicinal Plants | 2021-2025 | 473 | SG 1 | 71.15 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 477 | SG 4 | 69.50 |
| Flavonoids in Medical Research | 2021-2025 | 317 | SG 1 | 54.70 |
| Phytochemical compounds biological activities | 2021-2025 | 773 | SG 2 | 53.02 |
| Berberine and alkaloids research | 2021-2025 | 504 | SG 1 | 50.88 |
| Cell death mechanisms and regulation | 2021-2025 | 816 | SG 5 | 46.76 |
| Piperaceae Chemical and Biological Studies | 2021-2025 | 603 | SG 2 | 38.68 |
